Screening of coexpression genes of immune cells in breast cancer tissues
- PMID: 38181289
- PMCID: PMC10766216
- DOI: 10.1097/MD.0000000000036211
Screening of coexpression genes of immune cells in breast cancer tissues
Abstract
This study aimed to investigate immune cell infiltration (ICI) in breast cancer tissues and its impact on the prognosis of patients. The whole transcriptome sequencing data sets of breast tissue (GSE126125, GSE190275 and GSE45498) were downloaded from Gene Expression Omnibus database. Data sets, including 281 breast cancer tissue samples and 59 normal breast tissue samples. In this study, the CIBERSORT algorithm was used to calculate the infiltration content of 22 immune cells subtypes in breast cancer tissues and normal breast tissues. The ICI between normal and breast cancer tissue samples was examined through the Rank-sum test. Furthermore, Kaplan-Meier and the log-rank test were used for survival analysis. Univariate and multivariate COX analysis was used to screen the prognostic risk factors of breast cancer based on ICI. The correlation between 22 kinds of immune cells was analyzed by the Pearson test. The results of univariate COX analysis indicated that resting dendritic cells, eosinophils, resting mast cells, monocytes, and memory CD4 T cells resting were protective factors for the prognosis of breast cancer patients (hazard ratio [HR] < 1, P < .05). The activation of macrophage M0 and mast cells were also prognostic risk factors for breast cancer patients (HR > 1, P < .05). Besides, multivariate COX analysis showed that resting mast cells were independent protective factors for the prognosis of breast cancer patients (HR < 1, P < .05). Macrophage M0 and mast cell activation were independent risk factors for the prognosis of breast cancer patients (HR > 1, P < .05). High infiltration of macrophage M0 and activated mast cells is associated with poor prognosis. Meanwhile, macrophage M0 and activated mast cells promote breast cancer progression. Low infiltration of resting mast cells is associated with poor prognosis, which inhibits breast cancer progression.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures





Similar articles
-
Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer.BMC Med Genomics. 2022 Jul 25;15(1):164. doi: 10.1186/s12920-022-01318-5. BMC Med Genomics. 2022. PMID: 35879790 Free PMC article.
-
Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.Crit Rev Eukaryot Gene Expr. 2021;31(4):71-79. doi: 10.1615/CritRevEukaryotGeneExpr.2021038876. Crit Rev Eukaryot Gene Expr. 2021. PMID: 34587437
-
Analysis of genomics and immune infiltration patterns of epithelial-mesenchymal transition related to metastatic breast cancer to bone.Transl Oncol. 2021 Feb;14(2):100993. doi: 10.1016/j.tranon.2020.100993. Epub 2020 Dec 14. Transl Oncol. 2021. PMID: 33333372 Free PMC article.
-
Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma.Ann Transl Med. 2019 Dec;7(23):730. doi: 10.21037/atm.2019.11.117. Ann Transl Med. 2019. PMID: 32042746 Free PMC article.
-
[Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database].Beijing Da Xue Xue Bao Yi Xue Ban. 2022 Apr 18;54(2):203-208. doi: 10.19723/j.issn.1671-167X.2022.02.001. Beijing Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35435180 Free PMC article. Chinese.
References
-
- Loibl S, Poortmans P, Morrow M, et al. . Breast cancer. Lancet. 2021;397:1750–69. - PubMed
-
- Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389:1134–50. - PubMed
-
- Trayes KP, Cokenakes S. Breast cancer treatment. Am Fam Physician. 2021;104:171–8. - PubMed
-
- Peart O. Metastatic breast cancer. Radiol Technol. 2017;88:519M–39M. - PubMed
-
- Kim MY. Breast cancer metastasis. Adv Exp Med Biol. 2021;1187:183–204. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials